324 related articles for article (PubMed ID: 16217049)
1. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage.
Toyoda K; Okada Y; Minematsu K; Kamouchi M; Fujimoto S; Ibayashi S; Inoue T
Neurology; 2005 Oct; 65(7):1000-4. PubMed ID: 16217049
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study.
Toyoda K; Yasaka M; Nagata K; Nagao T; Gotoh J; Sakamoto T; Uchiyama S; Minematsu K;
Cerebrovasc Dis; 2009; 27(2):151-9. PubMed ID: 19039219
[TBL] [Abstract][Full Text] [Related]
3. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
4. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
5. Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage.
Caso V; Paciaroni M; Venti M; Alberti A; Palmerini F; Milia P; Billeci AM; Silvestrelli G; Biagini S; Agnelli G
Cerebrovasc Dis; 2007; 24(2-3):215-8. PubMed ID: 17630480
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet use after intracerebral hemorrhage.
Viswanathan A; Rakich SM; Engel C; Snider R; Rosand J; Greenberg SM; Smith EE
Neurology; 2006 Jan; 66(2):206-9. PubMed ID: 16434655
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Mark B; Zahn R; Senges J; Gottwik M
Thromb Haemost; 2008 Jan; 99(1):155-60. PubMed ID: 18217148
[TBL] [Abstract][Full Text] [Related]
8. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
9. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality.
Lacut K; Le Gal G; Seizeur R; Prat G; Mottier D; Oger E
Fundam Clin Pharmacol; 2007 Jun; 21(3):327-33. PubMed ID: 17521302
[TBL] [Abstract][Full Text] [Related]
11. Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease.
Itabashi R; Mori E; Furui E; Sato S; Yazawa Y; Fujiwara S
Thromb Res; 2011 Dec; 128(6):541-6. PubMed ID: 21741075
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Lee MS; Smith SD; Galor A; Hoffman GS
Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
[TBL] [Abstract][Full Text] [Related]
15. Predictors of outcome in warfarin-related intracerebral hemorrhage.
Zubkov AY; Mandrekar JN; Claassen DO; Manno EM; Wijdicks EF; Rabinstein AA
Arch Neurol; 2008 Oct; 65(10):1320-5. PubMed ID: 18852345
[TBL] [Abstract][Full Text] [Related]
16. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study.
Vernooij MW; Haag MD; van der Lugt A; Hofman A; Krestin GP; Stricker BH; Breteler MM
Arch Neurol; 2009 Jun; 66(6):714-20. PubMed ID: 19364926
[TBL] [Abstract][Full Text] [Related]
17. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
18. Associations of durations of antiplatelet use and vascular risk factors with the presence of cerebral microbleeds.
Yamashiro K; Tanaka R; Okuma Y; Ueno Y; Tanaka Y; Hattori N; Urabe T
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):433-40. PubMed ID: 23635924
[TBL] [Abstract][Full Text] [Related]
19. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
Reaume KT; Regal RE; Dorsch MP
Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
[TBL] [Abstract][Full Text] [Related]
20. [Benefits and risks of antiplatelet therapy. A retrospective study].
Nishimaru K; Yamaguchi T
Nihon Rinsho; 1992 Feb; 50(2):392-6. PubMed ID: 1613996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
